Next-generation genomics can be described as the combination of sequencing technologies and big data analytics. The potential impact of this disruptive technology in health care will be primarily realized through extending and enhancing lives through faster disease detection, more precise diagnoses, new drugs, and more tailored disease treatments. The technical challenges inherent in genetic engineering technology are great but may be less formidable than the social, ethical, and regulatory concerns it may generate. Please join us for a discussion of the possibilities and the challenges of next-generation genomics and implications for health care worldwide.

The panel of speakers include Timothy Behrens, Senior Director, Human Genetics, Genentech, Francis deSouza, President, Illumina Corporation, Robert L. Nussbaum, Chief, Department of Medicine & UCSF Institute for Human Genetics, UCSF.

The discussion is moderated by Michael Chui, Partner, McKinsey Global Institute.

For more information about this event please visit: http://www.worldaffairs.org/event-calendar/event/1298